Itamar Medical - WatchPATTM  / EndoPATTM  

WatchPAT™

WatchPAT™ is listed with FDA, CE and TGA and is a portable diagnostic device that uses the most innovative technology to ensure the accurate screening, detection, and the follow-up treatment of sleep apnea. Its ease of use is unparalleled in the marketplace and it is greatly complemented by the fact that WatchPAT™ testing is done in the comfort of your patient’s own bedroom, an environment that best reflects the pattern of their sleep habits. That fact alone may prove to be a lifeline for the millions of undiagnosed patients who are unwilling to spend the night away from home in a hospital sleep centre. And for those patients who are waiting for a polysomnography (PSG) but can’t be tested due to sleep centre backlog, WatchPAT™ offers an immediate solution. WatchPAT™ has been validated against PSG.

 

Features and Advantages:

  • Access to raw data – enabling standard sleep expert PSG analysis and manual override if deemed professionally necessary
  • Actual sleep time and sleep state
  • Ease of use: wrist-worn device

  • Lowest failure rate of all sleep apnea ambulatory devices
  • Sleep study report in real time
  • The most precise, user-friendly ambulatory sleep apnea monitor available

EndoPAT™

EndoPAT™ is the leading medical device for noninvasive endothelial function assessment. It is listed with FDA, CE and TGA, used in pre-eminent clinical and research institutions, major epidemiological population-based studies (such as Framingham Heart Study), and pharmaceutical clinical phase studies in over 40 countries. Thousands of tests are performed every month.

Features and Advantages:

  • Contra-lateral arm monitors systemic changes
  • Easy to use
  • Listed with FDA, CE and TGA 
  • Noninvasive
  • Office-based
  • Reliable and reproducible results
  • Supports both clinical and research applications
  • User independent